Axsome Therapeutics ($AXSM) Insider Trading & Smart Money Activity
Axsome Therapeutics, Inc. ($AXSM) has 11 13F position changes and 1 analyst rating on file.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 11
- Analyst ratings on file
- 1
AXSM insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 6 / 5 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All AXSM insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | TD Cowen | Reiterates to buy | PT $300 | -5.6% | -8.8% | Read | |||||
| 13F | Two Sigma Investments | Added | +177.18K sh | $79.01M | +3.6% | +11.3% | — | ||||
| 13F | Squarepoint Ops | Reduced | -40.90K sh | $27.93M | +3.6% | +11.3% | — | ||||
| 13F | Qube Research & Technologies | Added | +9.89K sh | $82.08M | +3.6% | +11.3% | — | ||||
| 13F | Point72 Asset Management, L.P. | Added | +406.75K sh | $103.97M | +3.6% | +11.3% | — | ||||
| 13F | Nomura Asset Management International | Reduced | -176.64K sh | $198.95M | +3.6% | +11.3% | — | ||||
| 13F | Adage Capital Partners Gp, L.L.C. | Added | +370K sh | $180.54M | +3.6% | +11.3% | — | ||||
| 13F | Metlife Investment Management | Reduced | -12.23K sh | $37.36M | +0.6% | +9.1% | — | ||||
| 13F | Walleye Capital | Reduced | -24.98K sh | $8.60M | +5.0% | +13.8% | — | ||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -30K sh | +5.5% | +6.8% | — | |||||
| 13F | Hb Wealth Management | Added | +16.14K sh | $12.30M | +19.4% | +25.1% | — | ||||
| 13F | Assenagon Asset Management S.A. | Added | +397.98K sh | $211.96M | -0.7% | +22.2% | — |
1W / 1M / 6M = how AXSM moved from the trade or filing date.
Institutions moving AXSM (13F)
- Two Sigma Investments1
- Squarepoint Ops1
- Qube Research & Technologies1
- Point72 Asset Management, L.P.1
- Nomura Asset Management International1
- Adage Capital Partners Gp, L.L.C.1
- Metlife Investment Management1
- Walleye Capital1
- Dekabank Deutsche Girozentrale1
- Hb Wealth Management1
- Assenagon Asset Management S.A.1
Analyst ratings on AXSM
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| TD Cowen | Reiterates | buy | $300 | -5.6% | -8.8% | Read |
Frequently asked questions
Which institutions changed their AXSM positions?
Recent 13F filers moving the stock include Two Sigma Investments, Squarepoint Ops, Qube Research & Technologies, Point72 Asset Management, L.P. and Nomura Asset Management International.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.